TY  - GEN
AU  - Eve,Heather E
AU  - Gambell,Jo
AU  - Smith,Paul
AU  - Qian,Wendi
AU  - Rule,Simon A J
TI  - The Simplified Mantle-Cell Lymphoma International Prognostic Index predicts overall survival but not progression-free survival in patients with mantle-cell lymphoma treated with fludarabine and cyclophosphamide +/- rituximab: results of a randomized phase II trial
SN  - 1029-2403
PY  - 2010///0329
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antibodies, Monoclonal
KW  - administration & dosage
KW  - Antibodies, Monoclonal, Murine-Derived
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Cyclophosphamide
KW  - Disease-Free Survival
KW  - Female
KW  - Humans
KW  - Kaplan-Meier Estimate
KW  - Lymphoma, Mantle-Cell
KW  - drug therapy
KW  - Male
KW  - Middle Aged
KW  - Prognosis
KW  - Rituximab
KW  - Severity of Illness Index
KW  - Survival
KW  - Treatment Outcome
KW  - Vidarabine
N1  - Publication Type: Clinical Trial, Phase II; Comparative Study; Letter; Randomized Controlled Trial; Validation Study
UR  - https://doi.org/10.1080/10428190903186494
ER  -